CARC 55: Procedure/treatment/drug is deemed experimental/investigational by the payer.
The carrier classified the treatment as experimental. Appealable when FDA-approved, peer-reviewed, or guideline-recommended for your specific indication.
CARC 55 is the code your insurance company used to explain why your claim was reduced, denied, or paid less than expected. It appears on your Explanation of Benefits (EOB) — the statement your plan sends after a claim is processed. Here's what it means for you and what you can do about it.
What CARC 55 means
The official X12 description is: “Procedure/treatment/drug is deemed experimental/investigational by the payer.”
In plain language: The carrier classified the treatment as experimental. Appealable when FDA-approved, peer-reviewed, or guideline-recommended for your specific indication.
Common scenarios
- Off-label oncology drug use
- Newer biologic
- Genetic testing for treatment selection
- Functional medicine therapies
What to do next 55
Appeal by citing FDA approval for your indication, peer-reviewed literature supporting the treatment, and specialty-society guidelines. Insurers often misapply 'experimental' to off-label-but-evidence-based treatments. For cancer, NCCN compendium use is particularly strong.
DenialHelp drafts the appeal letter for you in about five minutes. We cite the federal appeal-rights regulation that applies to your plan type (ACA §2719, ERISA §503, NSA §2799A, 42 CFR 422 Subpart M, or 42 CFR 438 Subpart F), the insurer's own coverage policy, and the relevant clinical guideline.
CARC 55 group codes explained
On the 835 ERA, CARC 55 appears alongside a group code that signals who is financially responsible for the adjustment. CO (Contractual Obligation) — Contractual write-off. The provider agreed to the rate. Patient does NOT owe this amount.
Frequently asked questions
What does CARC 55 mean?
Procedure/treatment/drug is deemed experimental/investigational by the payer. In plain language: The carrier classified the treatment as experimental. Appealable when FDA-approved, peer-reviewed, or guideline-recommended for your specific indication.
Is CARC 55 appealable?
Yes — CARC 55 is one of the codes that commonly supports an appeal. Appeal by citing FDA approval for your indication, peer-reviewed literature supporting the treatment, and specialty-society guidelines. Insurers often misapply 'experimental' to off-label-but-evidence-based treatments. For cancer, NCCN compendium use is particularly strong.
Which group code does CARC 55 appear under?
CARC 55 most often appears under: CO (Contractual Obligation) — Contractual write-off. The provider agreed to the rate. Patient does NOT owe this amount.
When does CARC 55 typically appear on a denial?
Common scenarios: Off-label oncology drug use; Newer biologic; Genetic testing for treatment selection; Functional medicine therapies.
How do I appeal a CARC 55 denial?
Appeal by citing FDA approval for your indication, peer-reviewed literature supporting the treatment, and specialty-society guidelines. Insurers often misapply 'experimental' to off-label-but-evidence-based treatments. For cancer, NCCN compendium use is particularly strong.
Related appeal verticals
- Cancer treatmentsChemo, immunotherapy, CAR-T, proton, PET, off-label per NCCN
- Specialty biologicsHumira, Enbrel, Stelara, Skyrizi, Cosentyx, Rinvoq, Dupixent
- Genetic testingBRCA, hereditary cancer panels, NIPT, tumor profiling, MRD
- Rare disease — ERT, substrate reduction, gene therapyPompe, Fabry, Gaucher, MPS, Batten, NPC, PKU
Sources
Appeal a CARC 55 denial
Upload your denial letter — DenialHelp drafts the physician-ready appeal in five minutes with the right clinical guideline and federal regulation cited. $39 first-level — money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com